Skip to main content

Euclidean Technologies Management, LLC

SEC CIK
0001597864
Latest filing
Apr 26, 2023

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Euclidean Technologies Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q1 2023 holdings

Shares (Q1 2023)
263
Value
$216.1K
% of portfolio
0.2%
Quarters held
1
Since Q1 2023
Holdings of REGN by Euclidean Technologies Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 2023263$216.1K0.2%+263NewHolders